Secondary Logo

Most Popular Articles

Clinical management of localized undifferentiated sinonasal carcinoma: our experience and review of the literature

Perri, Francesco; Della Vittoria Scarpati, Giuseppina; Ionna, Franco; More

Anti-Cancer Drugs. 30(3):308-312, March 2019.

Palbociclib has no clinically relevant effect on the QTc interval in patients with advanced breast cancer

Durairaj, Chandrasekar; Ruiz-Garcia, Ana; Gauthier, Eric R.; More

Anti-Cancer Drugs. 29(3):271-280, March 2018.

Preclinical testing of 5-amino-1-((1R,2S,3S,4R)-2,3-dihydroxy-4-methylcyclopentyl)-1H-imidazole-4-carboxamide: a potent protein kinase C-ι inhibitor as a potential prostate carcinoma therapeutic

Apostolatos, André H.; Apostolatos, Christopher A.; Ratnayake, Wishrawana S.; More

Anti-Cancer Drugs. 30(1):65-71, January 2019.

FoxM1 promotes epithelial–mesenchymal transition, invasion, and migration of tongue squamous cell carcinoma cells through a c-Met/AKT-dependent positive feedback loop

Yang, Huiling; Wen, Li; Wen, Mingling; More

Anti-Cancer Drugs. 29(3):216-226, March 2018.

A case of heavily pretreated metastatic cardiac angiosarcoma treated successfully using eribulin

Inagaki, Chiaki; Shimoi, Tatsunori; Okuma, Hitomi; More

Anti-Cancer Drugs. 29(1):97-101, January 2018.

DZ-2384 has a superior preclinical profile to taxanes for the treatment of triple-negative breast cancer and is synergistic with anti-CTLA-4 immunotherapy

Bernier, Cynthia; Soliman, Ahmed; Gravel, Michel; More

Anti-Cancer Drugs. 29(8):774-785, September 2018.

A randomized phase II study to determine the efficacy and tolerability of two doses of eribulin plus lapatinib in trastuzumab-pretreated patients with HER-2-positive metastatic breast cancer (E-VITA)

Bischoff, Joachim; Barinoff, Jana; Mundhenke, Christoph; More

Anti-Cancer Drugs. 30(4):394-401, April 2019.

YM155, a novel survivin suppressant, enhances taxane-induced apoptosis and tumor regression in a human Calu 6 lung cancer xenograft model

Nakahara, Takahito; Yamanaka, Kentaro; Hatakeyama, Shinji; More

Anti-Cancer Drugs. 22(5):454-462, June 2011.

Reduced folate and serum vitamin metabolites in patients with rectal carcinoma: an open-label feasibility study of pemetrexed with folic acid and vitamin B12 supplementation

Stoffregen, Clemens C.; Odin, Elisabeth A.; Carlsson, Göran U.; More

Anti-Cancer Drugs. 27(5):439-446, June 2016.

Venous thromboembolic events in patients with lung cancer treated with cisplatin-based versus carboplatin/nedaplatin-based chemotherapy

Mitani, Akihisa; Jo, Taisuke; Yasunaga, Hideo; More

Anti-Cancer Drugs. 29(6):560-564, July 2018.

Extended topoisomerase 1 inhibition through liposomal irinotecan results in improved efficacy over topotecan and irinotecan in models of small-cell lung cancer

Leonard, Shannon C.; Lee, Helen; Gaddy, Daniel F.; More

Anti-Cancer Drugs. 28(10):1086-1096, November 2017.

The role of Ki-67 in the proliferation and prognosis of breast cancer molecular classification subtypes

Stathopoulos, George P.; Malamos, Nikolaos A.; Markopoulos, Christos; More

Anti-Cancer Drugs. 25(8):950-957, September 2014.

Complete response after rechallenge with trabectedin in a patient with previously responding high-grade undifferentiated sarcoma

Baldi, Giacomo G.; Di Donato, Samantha; Fargnoli, Rossana; More

Anti-Cancer Drugs. 27(9):908-913, October 2016.

Dual compartmental targeting of cell cycle and angiogenic kinases in colorectal cancer models

Capasso, Anna; Pitts, Todd M.; Klauck, Peter J.; More

Anti-Cancer Drugs. 29(9):827-838, October 2018.

Generation of a humanized anti-glypican 3 antibody by CDR grafting and stability optimization

Nakano, Kiyotaka; Ishiguro, Takahiro; Konishi, Hiroko; More

Anti-Cancer Drugs. 21(10):907-916, November 2010.

Real-world healthcare costs of ipilimumab in patients with advanced cutaneous melanoma in The Netherlands

Franken, Margreet G.; Leeneman, Brenda; Jochems, Anouk; More

Anti-Cancer Drugs. 29(6):579-588, July 2018.

Trabectedin in advanced synovial sarcomas: a multicenter retrospective study from four European institutions and the Italian Rare Cancer Network

Sanfilippo, Roberta; Dileo, Palma; Blay, Jean-Yves; More

Anti-Cancer Drugs. 26(6):678-681, July 2015.

Rapid up-regulation of cyclooxygenase-2 by 5-fluorouracil in human solid tumors

Mercer, Stuart J.; Di Nicolantonio, Federica; Knight, Louise A.; More

Anti-Cancer Drugs. 16(5):495-500, June 2005.

Gosha-jinki-gan reduced oxaliplatin-induced hypersensitivity to cold sensation and its effect would be related to suppression of the expression of TRPM8 and TRPA1 in rats

Kato, Yoshinori; Tateai, Yoshikazu; Ohkubo, Misao; More

Anti-Cancer Drugs. 25(1):39-43, January 2014.

Cytotoxicity and molecular activity of fenretinide and metabolites in T-cell lymphoid malignancy, neuroblastoma, and ovarian cancer cell lines in physiological hypoxia

Song, Michael M.; Makena, Monish R.; Hindle, Ashly; More

Anti-Cancer Drugs. 30(2):117-127, February 2019.

Treatment of relapsed urothelial bladder cancer with vinflunine: real-world evidence by the Hellenic Genitourinary Cancer Group

Pistamaltzian, Nikolaos; Tzannis, Kimon; Pissanidou, Vassiliki; More

Anti-Cancer Drugs. 27(1):48-53, January 2016.

Show: